Introduction/Background This study examines the evolving trends of complications post-gynecologic oncology surgeries and explores the influence of a comprehensive registry on intervention strategies and temporal outcomes.

Methodology A comprehensive analysis encompassed a diverse range of gynecologic oncology cases from April 2021 to November 2023. This involved an extensive evaluation of patient demographics, cancer types, International Federation of Gynecology and Obstetrics (FIGO) stages, surgical approaches, and Clavien-Dindo graded outcomes. Statistical analyses, such as chi-square tests and ANOVA, were employed to discern temporal patterns.

Results Out of 711 surgeries analyzed, 138 complications surfaced, yielding an overall complication rate of 19.41%. Notable complications included pelvic hematoma (18.0%), urinary tract infections (12.2%), dehiscence (11.5%), and surgical site infections (5.8%). A significant majority (74.64%) were mild (Clavien-Dindo I-II). The fluctuating rates of complications across semesters ranged from 13.10% to 27.83%. No substantial temporal associations were evident between Clavien-Dindo categories I-II and III-IV (χ² = 23.389, df = 20, p = 0.270). Instances of Clavien-Dindo type V complications appeared sporadic, relying on 1–2 cases or none, possibly due to chance. External evaluation by IASIST demonstrated a declining risk-adjusted complication ratio from 2019 (1.2) to 2022 (0.8), coinciding with the comprehensive registry implementation, signifying enhanced patient care.

Conclusion This study presents the evolving landscape of complications in gynecologic oncology surgeries, revealing fluctuating trends across semesters. Continuous refinement in strategies and vigilant monitoring remain imperative for optimal patient care outcomes without unequivocally suggesting a universal improvement trend.

Disclosures No conflicts of interest exist.

• Download figure
• Open in new tab
• Download powerpoint

Abstract 1023 Figure 1